A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways

Abstract Triple-negative breast cancer (TNBC) is a high-risk subtype of breast cancer with high capacity for metastasis and lacking of therapeutic targets. Our previous studies indicated that cystathionine γ-lyase (CSE) may be a new target related to the recurrence or metastasis of TNBC. Downregulat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ya Liu, Lupeng Wang, Xiuli Zhang, Yuying Deng, Limin Pan, Hui Li, Xiaoyan Shi, Tianxiao Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6ee730420102402986db3c8ac9a8330d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ee730420102402986db3c8ac9a8330d
record_format dspace
spelling oai:doaj.org-article:6ee730420102402986db3c8ac9a8330d2021-12-02T13:41:00ZA novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways10.1038/s41598-021-88355-92045-2322https://doaj.org/article/6ee730420102402986db3c8ac9a8330d2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88355-9https://doaj.org/toc/2045-2322Abstract Triple-negative breast cancer (TNBC) is a high-risk subtype of breast cancer with high capacity for metastasis and lacking of therapeutic targets. Our previous studies indicated that cystathionine γ-lyase (CSE) may be a new target related to the recurrence or metastasis of TNBC. Downregulation of CSE could inhibit the growth and metastasis of TNBC. The purpose of this study was to investigate the activity of the novel CSE inhibitor I194496 against TNBC in vivo and in vitro. The anticancer activity of I194496 in vitro were detected by MTS, EdU, and transwell assays. Methylene blue assay was used to determine the H2S level. Western blot was performed to analyze the expression of related pathway proteins. Xenograft tumors in nude mice were used to analyze the anticancer activity of I194496 in vivo. I194496 exerted potent inhibitory effects than l-propargylglycine (PAG, an existing CSE inhibitor) on human TNBC cells and possessed lower toxicity in normal breast epithelial Hs578Bst cells. I194496 reduced the activity and expression of CSE protein and the release of H2S in human TNBC cells. Meanwhile, the protein levels of PI3K, Akt, phospho (p)-Akt, Ras, Raf, p-ERK, p-Anxa2, STAT3, p-STAT3, VEGF, FAK, and Paxillin were decreased in human TNBC cells administrated with I194496. Furthermore, I194496 showed more stronger inhibitory effects on human TNBC xenograft tumors in nude mice. I194496 could inhibit the growth of human TNBC cells via the dual targeting PI3K/Akt and Ras/Raf/ERK pathway and suppress the metastasis of human TNBC cells via down-regulating Anxa2/STAT3 and VEGF/FAK/Paxillin signaling pathways. CSE inhibitor I194496 might become a novel and potential agent in the treatment of TNBC.Ya LiuLupeng WangXiuli ZhangYuying DengLimin PanHui LiXiaoyan ShiTianxiao WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ya Liu
Lupeng Wang
Xiuli Zhang
Yuying Deng
Limin Pan
Hui Li
Xiaoyan Shi
Tianxiao Wang
A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
description Abstract Triple-negative breast cancer (TNBC) is a high-risk subtype of breast cancer with high capacity for metastasis and lacking of therapeutic targets. Our previous studies indicated that cystathionine γ-lyase (CSE) may be a new target related to the recurrence or metastasis of TNBC. Downregulation of CSE could inhibit the growth and metastasis of TNBC. The purpose of this study was to investigate the activity of the novel CSE inhibitor I194496 against TNBC in vivo and in vitro. The anticancer activity of I194496 in vitro were detected by MTS, EdU, and transwell assays. Methylene blue assay was used to determine the H2S level. Western blot was performed to analyze the expression of related pathway proteins. Xenograft tumors in nude mice were used to analyze the anticancer activity of I194496 in vivo. I194496 exerted potent inhibitory effects than l-propargylglycine (PAG, an existing CSE inhibitor) on human TNBC cells and possessed lower toxicity in normal breast epithelial Hs578Bst cells. I194496 reduced the activity and expression of CSE protein and the release of H2S in human TNBC cells. Meanwhile, the protein levels of PI3K, Akt, phospho (p)-Akt, Ras, Raf, p-ERK, p-Anxa2, STAT3, p-STAT3, VEGF, FAK, and Paxillin were decreased in human TNBC cells administrated with I194496. Furthermore, I194496 showed more stronger inhibitory effects on human TNBC xenograft tumors in nude mice. I194496 could inhibit the growth of human TNBC cells via the dual targeting PI3K/Akt and Ras/Raf/ERK pathway and suppress the metastasis of human TNBC cells via down-regulating Anxa2/STAT3 and VEGF/FAK/Paxillin signaling pathways. CSE inhibitor I194496 might become a novel and potential agent in the treatment of TNBC.
format article
author Ya Liu
Lupeng Wang
Xiuli Zhang
Yuying Deng
Limin Pan
Hui Li
Xiaoyan Shi
Tianxiao Wang
author_facet Ya Liu
Lupeng Wang
Xiuli Zhang
Yuying Deng
Limin Pan
Hui Li
Xiaoyan Shi
Tianxiao Wang
author_sort Ya Liu
title A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
title_short A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
title_full A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
title_fullStr A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
title_full_unstemmed A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways
title_sort novel cystathionine γ-lyase inhibitor, i194496, inhibits the growth and metastasis of human tnbc via downregulating multiple signaling pathways
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6ee730420102402986db3c8ac9a8330d
work_keys_str_mv AT yaliu anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT lupengwang anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT xiulizhang anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT yuyingdeng anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT liminpan anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT huili anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT xiaoyanshi anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT tianxiaowang anovelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT yaliu novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT lupengwang novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT xiulizhang novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT yuyingdeng novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT liminpan novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT huili novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT xiaoyanshi novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
AT tianxiaowang novelcystathionineglyaseinhibitori194496inhibitsthegrowthandmetastasisofhumantnbcviadownregulatingmultiplesignalingpathways
_version_ 1718392622348763136